Clinical Trials
7 trialsNCT07612787 2026-06-15
BELAMI
Centre Hospitalier Universitaire de Saint Etienne
Phase 1/2 Not yet recruiting
NCT06429150 2026-04-24
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Recruiting
NCT07340853 2026-03-10
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
University of California, San Francisco
Phase 1 Recruiting
NCT07458659 2026-03-09
CART-BCMA
Chulalongkorn University
Phase EARLY_PHASE1 Not yet recruiting
NCT07051850 2025-07-15
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
Seoul St. Mary's Hospital
Recruiting
NCT03271632 2019-09-19
Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT01886976 2016-01-28
CART-138
Chinese PLA General Hospital
Phase 1/2 Unknown